ArticleCell death discovery2016

Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer.

Y-Y Hsieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.